This study investigated the serum levels of HIF-1α and VEGF in CTD-PAH patients and analyzed their clinical relevance, aiming to establish HIF-1α and VEGF as potential diagnostic biomarkers for CTD-PAH. Here, VEGFA is linked to pulmonary arterial hypertension.